Glenmark Pharmaceuticals could miss January-March earnings consensus forecast, according to Thomson Reuters StarMine data.
[caption id=“attachment_755489” align=“alignleft” width=“380”] Shares in Glenmark were up 1.9 percent at 12:24 a.m. The company will announce its earnings on Tuesday. Reuters[/caption]
StarMine’s SmartEstimates, which places greater emphasis on forecasts by top-rated analysts, shows Glenmark could report a net profit of Rs 156 crore for the quarter, compared with a mean consensus estimate of Rs 168 crore.
Shares in Glenmark were up 1.9 percent at 12:24 a.m. The company will announce its earnings on Tuesday.
STORY CONTINUES BELOW THIS AD
Reuters
End of Article